test enough off-set loss normal
volum quest modestli lower fve
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim apr
price data apr
rate updat apr
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
posit lead provid
independ diagnost test build network
patient servic center across countri
think quest size cost advantag allow benefit
sever secular trend includ prolifer diagnost
test greater clinic relianc person therapi
addit expect longer term reimburs
pressur push hospital-bas lab small independ
outsourc volum largest lowest-cost produc
quest primari nation competitor labcorp domin
independ diagnost test landscap thank vast nation
network laboratori two firm creat barrier
entri gener substanti cost advantag region
hospit lab industri seen steadi consolid
compani acquir smaller competitor recent
quest focus establish presenc hospital-bas
lab either oper consult basi contrast
portfolio
higher-margin esoter test acquisit ameripath
athena celera
histor pattern expand
importantli quest benefit key trend includ greater
activ manag care steer insur lower-cost lab
penetr high-deduct plan increas presenc
retail
despit quest formid size attract cost structur
firm histor trail peer labcorp oper effici
diagnost busi think firm recent shift toward
work hospital-bas lab could hamper effici even
due higher cost structur latter nonetheless
quest still reliabl gener econom profit underscor
strength moat current manag team spent
first four year focus on-going integr acquisit
play catch-up oper front streamlin
organ greater effici though took firm
profit final improv
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
lead independ provid diagnost test
inform servic compani gener
revenu clinic test anatom patholog esoter test
substanc abus test specimen collect nation
network patient servic center well multipl doctor offic
hospit firm also run diagnost solut segment
provid clinic trial test risk assess servic inform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
modestli trim fair valu estim
per share adjust major hit volum
second quarter follow stabil gradual
recoveri weve revis
revenu project second third fourth quarter
declin respect translat
full-year declin revenu weve also assum
subsequ recess damp growth reach
full recoveri consid signific oper
leverag weve bake oper margin declin
basi point follow two year recoveri
part care act recent pass respons
crisi pama cut schedul
suspend offer bit breath room lab
addit collect price volum data reset
next three-year cycl medicar cut delay
anoth year earli brief respit pama
cut major disrupt lead
estim larg flat averag annual top-lin growth
longer term think compani focu
esoter test pay pharmaceut
biotech compani aim person target
therapi expect steadi stream new biomark
discoveri greater applic molecular diagnost
across clinic spectrum bode well quest
base averag volatil cash flow
underli diagnost test busi think medium
uncertainti appropri quest
bull-cas scenario assum crisi
drive revenu follow
rel quick recoveri lead averag annual
top-lin growth coupl oper
margin contract basi point continu
expect mix shift toward esoter test drive
oper margin also assum routin
test volum price gain outperform adjust
medicar clinic lab fee schedul favor
expect greater-than-expect effici
realiz non-traditional allianc hospital-bas
lab case rais fair valu estim
bear-cas scenario project increment averag
annual revenu declin driven
top-lin declin follow slower-than-expect
recoveri also bake
declin oper margin mid-
longer term assum anatom patholog growth
remain flat in-sourc continu slowli
esoter test revenu growth exceed
firm benefit oper leverag
product mix turn unfavor headwind would
translat oper margin hover
averag put fair valu estim per share
quest enjoy narrow moat part duopoli
domin independ refer lab market compar
hospital-bas lab smaller region player
quest typic offer signific cost advantag thank
scale volum exampl test hospit lab
typic cost time averag test
quest advantag becom evid
throughput increas translat high oper
addit firm nationwid footprint
extens network patient servic center
in-physician offic servic would difficult replic
scratch quest advantag cost structur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
payer push financi risk onto provid made
doctor hospit price-sensit come
lab test dynam put end
encroach hospital-affili lab quest
labcorp busi hospital-bas lab
gain market share independ thank
gener reimburs polici favor hospit
set concurr move toward hospit
purchas physician practic direct test
hospit lab hospit begun pull
back invest lab reli independ lab
outsourc test also mean primari
advantag largest independ refer lab -- lower
cost -- grow relev practition payer
nation coverag also appeal payer
structur reimburs polici funnel patient
larg independ lab payer would typic rather
negoti largest refer lab includ quest
provid best geograph coverag insur
instead cobbl togeth market-by-market
coverag multipl smaller region lab
seen larg payer includ
begin assert flex muscl
direct insur lowest-cost lab
challeng significantli higher price hospital-bas
lab demand diagnost test final quest scale
reach make attract partner research
invent variou diagnost test distribut
channel sell test
hold quest moat trend stabl larg
weak util rel well key trend
diagnost lab market add favor condit
independ lab specif new experi among
includ autom
integr autom
quest one key challeng maintain moat
continu lower cost structur quest key lever
endeavor
technolog consolid lab facil
meantim expect quest continu snap smaller
competitor
oper think firm like moder
acquisit larger target offer higher-margin
complex test capabl work integr
sizabl purchas alreadi made recent quest
pursu opportun manag hospital-bas
lab type arrang
econom attract wholesal purchas
non-inpati
non-outpati think firm done credibl job
margin expans even contract manag
hospital-bas lab ad mix
competit quest labcorp remain ration
point think irrat price unlik long
higher-pr rival like hospit constitut primari
competit payer step focu
reduc usag higher-pr diagnost lab
seen mark chang negoti strategi labcorp
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
quest exampl follow expir
exclus contract labcorp
largest privat payer contract quest
labcorp effort drive insur
lowest-cost produc instead pit labcorp
quest squeez increment save
put low-cost produc prefer lab network
increas access low-cost produc activ
nudg insur away higher-cost hospital-bas
final think opportun industri
horizon move away
volume-bas
reimburs could posit independ
diagnost lab healthcar reform shepherd
reimburs valu instead volum think
opportun diagnost firm captur
valu histor elud industri industri
estim diagnost test account less total
healthcar spend influenc approxim
treatment decis industri demonstr
valu think quest competitor could captur
larger portion healthcar pie
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oadvanc technolog person medicin
increas number complex esoter
gene-bas test avail patient test
gener carri higher profit margin quest
oquest activ seek hospital-outreach
program roll acquisit offer
attract econom quest
organ patient record lab test inform
databas doctor use
like refer patient quest facil
oif sizabl number hospital-bas lab fail
compli data collect report
requir pama expect improv
medicar reimburs may fail materi
oquest previou strateg foray indian
market anim health disappoint
ultim kept manag focus
improv oper quest mainstay routin
esoter test segment
oon anecdot basi consist heard
complaint patient poor servic quest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
even roll-up strategi quest maintain manag
balanc sheet activ contribut slight rise
leverag earli anoth tick upward
howev histor firm deleverag repay
debt expand profit follow heavi
acquisit activ decemb long-term debt stood
billion time ebitda estim debt/ebitda
push closer time time
manag gener aim anticip
quest return level end firm
debt oblig includ senior note due within next
five year million due million due
drive major declin test volum
firm could tap billion remain
borrow capac exist credit facil
also project major declin free cash flow
follow gradual recoveri even dip
still expect quest abl gener
roughli million annual free cash flow averag
next five year think
problem meet oblig
base averag volatil cash flow
underli diagnost test busi think medium
uncertainti appropri quest quest focus
pursu variou on-sit oper arrang
hospital-bas lab firm may abl realiz
mani oper effici roll hospit
outreach program could pose difficulti quest
enhanc profit think grow relianc
duplic test fall health system reli
proprietari electron medic record keep independ
lab favor intern hospital-bas lab lower
price larg insur would lead smaller profit
quest labcorp quest consist eke
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oper effici firm could see
profit buckl pressur payer
new cut medicar clinic lab fee schedul
reset cycl significantli sever
expect guidelin left hospital-bas
lab equat calcul market reimburs
rate test mean reimburs rate
aggreg influenc outsiz way quest
labcorp -- two lowest-cost produc
diagnost lab industri seen magnitud
cut take long enlarg
pool lab includ next cycl
reimburs adjust take place
mani healthcar situat must balanc goal
lower cost object patient access
expect medicar reimburs pressur continu
eas second cycl start
still think quest benefit either rise
reimburs rate hospital-bas lab
smaller independ lab decid shift volum
quest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ceo/chairman board/
repres date owner name posit common share held report holder issuer
share
fund
share
fund
stephen rusckowski leadership think quest
becom focus capital-alloc decis
introduc number improv make
govern shareholder-friendli like inclus
tim ring retir ceo cr bard board
long admir ring team disciplin prudent
deploy capit
quest adopt annual elect director
instead stagger three-year term previous
place quest shift away bonu target tie
earn per share toward metric includ revenu
growth return invest capit realiz cost
effici roll three-year perform period
believ compani past use stock option
compens excess think
dynam chang current manag -- rusckowski
award nearli million stock option award
first year quest recent rusckowski
share-bas
addit would like see manag
director take larger equiti stake firm execut
offic director less stock
also unenthusiast quest chang design
nonexecut chairman board appoint
rusckowski posit augment
stanzion lead independ director
past particularli impress
firm record capit alloc mainli
cohes strategi guid invest
howev rusckowski leadership quest
focus acquir stand-alon lab special
esoter diagnost hospit outreach program
think move reinforc quest moat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
broaden firm menu test increas test
volum ultim contribut firm attract
cost structur howev wari firm effort
move deepli less-tradit arrang
hospital-bas lab manag oper
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
quest labcorp enter test market
chang fair valu estim
infect increas
surpris see diagnost lab giant quest diagnost
labcorp move full steam ahead
laboratory-develop test novel viru labcorp
test avail use doctor order start
yesterday quest start monday march
point increas fair valu estim
compani basi new
test though expect moder increas
valuat labcorp revisit assumpt
clinic trial busi clear test
price consid public health aspect
crisi wouldnt surpris price fall well short
typic price refer lab test detect
season influenza even lower point-
nonetheless quest labcorp swift develop
valid assay underscor
narrow econom moat skeptic multitud
smaller independ region lab abl
develop distribut test nearli
quickli also recogn quest labcorp distribut
infrastructur formid competit advantag
situat firm alreadi work larg
major hospit physician
anticip avail new test help
reliev test bottleneck current exist
center diseas control public laboratori
handl test
havent shift valuat taken
closer look new test might play quest
first blush peg test could boost
fair valu estim enough materi
move valuat start review health
human servic pandem scenario
project base case
eventu infect popul roughli
infect assum half seek outpati care
approxim million patient seek care
assum year older
reflect gener popul though ill
popul could well skew older
test high-risk
popul remain seek care
also assum receiv
diagnost test final assum public lab
handl test quest captur
charg per test test price
set increment cash flow impact would even
gener underscor gradual improv seen
expect modestli rais fair valu
estim account cash flow realiz havent made
chang underli assumpt
estim fall within manag outlook
particularli pleas see uptick volum growth
sustain second half translat
slightli improv adjust oper margin
full year took place backdrop
increas reimburs pressur stem
protect access medicar act
underscor confid quest narrow econom
moat along rival labcorp quest enjoy scale
nation coverag offer durabl cost advantag
quest abl pump test volum
lab infrastructur run test batch effici
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
smaller competitor firm abl weather
pama reimburs pressur grace
big question remain hospital-bas lab
come recogn substanti impact pama cut
lab profit suspect may see modest
increas hospit system take closer look lab
profit especi begun
implement special inform technolog
system help reveal perform lab
embed within larger hospit system wouldnt
surpris see integr deliveri network revis
opinion lab profit histor
base contribut margin base new
inform may see arrang like quest
impend acquisit memori hermann outreach
program contract manag hospital-bas lab
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
